CASE STUDY | VIDEO
Biomarker that Elucidates a Drug’s Mechanism of Action
Today’s case study illustrates how metabolomics can help you unlock your biomarker discovery program.
In this example, our client needed to understand the mechanism of action of a promising new anticancer therapy. Traditional approaches to understanding MoA can be time consuming and expensive. Our client chose the precision of metabolomics to reveal a clear and novel biological pathway and a potential target for a much-needed new drug.